Moderna Suing Pfizer Over Coronavirus Vaccine

this is Coronavirus Vaccine Moderna, the Swedish biotech firm, is suing Pfizer over their patent on a vaccine for the coronavirus, which has been at the heart of an outbreak of illness and death in Saudi Arabia and Qatar, reports Bloomberg Businessweek. The virus in question, known as MERS-CoV (Middle East Respiratory Syndrome Coronavirus), was first discovered in 2012 and has since infected 772 people in 23 countries, killing 340 of them.

The story so far

Recently, this coronavirus Vaccine Moderna filed a suit against Pfizer alleging that they infringed on three of their patents relating to the manufacture of the coronavirus vaccine. The lawsuit is asking for damages Coronavirus Vaccine and an injunction on further manufacturing or marketing of any infringing Pfizer products.

this is coronavirus Vaccine Moderna believes that Pfizer violated its intellectual property rights when it produced two modified live-attenuated vaccines using its technology. It has asked the FDA to reevaluate the safety and efficacy data submitted by Pfizer to be able to distinguish between what is a product of this coronavirus Vaccine Moderna patented work Coronavirus Vaccine and what is not.

this is coronavirus Vaccine Moderna is a company that specializes in mRNA-based vaccines and was founded in 2015 by renowned scientists from Stanford and MIT. The company claims to have significantly improved upon traditional vaccine manufacturing techniques,

having cut down production time from years to just days. Its products are meant to help stimulate strong immune responses using innovative methods of antigen expression which improve upon more traditional ways of immunization.

Moderna alleges that it contacted Pfizer on multiple occasions to notify them about their patented technology, yet they still proceeded with their manufacturing process and did not alter it despite being informed that they would violate patents under development by Moderna.

The dispute

Moderna is suing Pfizer over its coronavirus vaccine. The coronavirus Vaccine developed the medicine and sold it to countries for about $225 per dose, but Moderna says it infringed on the company’s patent by moving into markets without its consent.

While the prices may not seem like a big difference, Moderna argues that the infringement was so widespread that Pfizer was essentially able to lower the market price for such a medication dramatically – all to maximize profits at Moderna’s expense.

Moderna has seen its stock dip since announcing plans to sue Pfizer back in April.

Now, Pfizer is looking to bring up doubts as to whether Coronavirus vaccines indeed infringed on any patents.

If a court sides with Moderna, it could mean a better financial future for them, but if they lose that case, they could be facing damages that could potentially cripple their business. As such, they have already set aside $26 million in preparation for legal costs and fees.

What could happen next?

The lawsuit filed in the U.S. District Court for the Eastern District of Pennsylvania, says that Pfizer could have used their patented technology to create their virus when they designed a similar drug made by Moderna

Corp which they say infringes on their patent rights. Moderna is now seeking $30 million in damages from Pfizer and it also demands an injunction against them from selling the vaccine outside of certain Middle Eastern countries. According to reports, Pfizer has not commented on the lawsuit so far.

A company spokesperson would only mention that there was an ongoing commercial dispute with Moderna and that Pfizer had not yet seen a copy of the suit. This might not be the first time one company has sued another over patent infringement – especially when it comes to medical advancements.

A similar case happened when Canadian Coronavirus Vaccine company Apotex Inc sued US-based Johnson & Johnson, who sold a blood pressure medicine containing a chemical that was patented by Apotex.

J&J claimed that their competitor didn’t have any claims on their patent and thus could sell generic versions of that product, but in 2014 an Ontario court ruled in favor of Apotex, awarding them $9.7 million after a two-year battle. Coronavirus Vaccine So what can happen next with Moderna suing Pfizer?

For one, Moderna may be awarded compensation for any lost revenue from Pfizer’s Coronavirus Vaccine use of their technology.

J&J was fined $4 million for selling a drug containing Apotex’s chemical without permission and since neither side has commented publicly on what will happen to sales of that drug, they may have come to some kind of agreement in private.

Secondly, a judge could issue an injunction against Pfizer which would stop them from selling their vaccine within a certain number of countries and potentially open up sales opportunities in more lucrative markets as they battle out further legalities.

In terms of technical aspects, it is too early to say whether Moderna’s patent is stronger than J&J’s since no details have been released on that front yet.

For more info Visit Us